Statin Use Cuts 5-Year Stroke Risk for Patients With Atrial Fibrillation
Benefits across stroke types seen in duration-dependent manner
Benefits across stroke types seen in duration-dependent manner
Association of hypertension, heart disease, and diabetes with stroke appears to be substantially reduced at older ages
GDF-15 adds predictive value to the HAS-BLED score for assessing major bleeding risk.
Findings were consistent for patients aged 80 years or older and patients with chronic kidney disease, who are often underrepresented in clinical trials.
Danish investigators compared direct oral anticoagulants with vitamin K antagonists in 33,670 patients with atrial fibrillation.
For those diagnosed with atrial fibrillation, hazard ratios for all-cause mortality, incident heart failure, ischemic stroke increased with higher BMI
Nondiagnostic tracings and false positives seen with smartwatch algorithm detection of AF in those with cardiac anomalies
Risks for ischemic stroke or systemic embolism, bleeding reduced with apixaban versus rivaroxaban for atrial fibrillation and valvular heart disease
Investigators sought to identify biomarkers for determining risk for developing HF and death in patients with atrial fibrillation.
Risk for atrial fibrillation is greater in women than men after adjusting for height, height and weight, or body surface area